Vincent Probst
Vincent Probst is an expert in Cardiology at Centre Hospitalier Universitaire de Nantes (France). As of October 2026, ScienceLeadR ranks Vincent Probst in the top 1% of experts worldwide for Cardiac Conduction System Disease, Heart Arrest and Cardiomyopathies. Vincent Probst has authored 444 publications, the most recent in 2026, and is an investigator in 43 clinical trials, 11 of them ongoing. SLR score: 2,040 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Public Health - Genetics - Biostatistics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2002 - 2026
Number : 444
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Genetic susceptibility in Takotsubo syndrome: a candidate gene association analysis in the French TAKOGENE cohort. PMID 42863705 — genes, stress, physiological, genetic predisposition to disease, population control, sex, polymorphism, single nucleotide, genetic diseases, inborn, cardiomyopathies, takotsubo cardiomyopathy | Eur J Med Genet | 2026 | 0 |
| Ajmaline or flecainide testing in Brugada syndrome: influence of SCN5A variants. PMID 42643111 — research design, cardiology, ajmaline, brugada syndrome, flecainide | Eur Heart J Top journal | 2026 | 0 |
| Comparison of Local Investigator and Core Laboratory Assessment of Cardiac MRI-derived Left Ventricular Ejection Fraction in the MyocarditIRM Study. PMID 42560173 — laboratories | Radiol Cardiothorac Imaging | 2026 | 0 |
| Subcutaneous Implantable Cardioverter-Defibrillator Therapy in Women. PMID 42554569 — mortality, epidemiology, cardiovascular diseases, cohort studies, heart arrest, sex, death, sudden, cardiac, therapeutics, defibrillators, implantable, defibrillators | JACC Clin Electrophysiol | 2026 | 0 |
| Intercentre heterogeneity and determinants of implantable cardioverter-defibrillator technology selection in France. PMID 42532733 — body mass index, cardiovascular diseases, defibrillators, implantable, defibrillators | Arch Cardiovasc Dis | 2026 | 0 |
Clinical Studies 43
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 6
Ongoing Clinical Trials
11 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| HeartLogic in Patients With Heart Failure NCT07544771 — quality of life, monitoring, ambulatory, hospitalization, heart failure, heart, symptom assessment, therapeutics, defibrillators, implantable, defibrillators | N/A | Recruiting | 2026 |
| Stratification of Arrhythmic Risk and or Heart Failure Risk in Patients With Hereditary Heart Disease NCT07257289 — heart diseases, heart failure, heart, biomarkers, cardiomyopathies, electrocardiography, defibrillators | N/A | Recruiting | 2026 |
| Identifying Electrocardiographic Markers to Determine Eligibility for the Implantation of a Subcutaneous Defibrillator NCT07157449 — electrocardiography, defibrillators | N/A | Recruiting | 2026 |
| Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment a French Prospective Register NCT06642168 — death, sudden, heart diseases, heart arrest, toxicology, diagnosis, death, sudden, cardiac, exome, exome sequencing, athletes, mutation, sports, autopsy | N/A | Recruiting | 2024 |
| Non interventional Study of Seroprevalence of Pre existing Antibodies Against Adenovirus associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2) Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) NCT06311708 — genes, antibodies, adenoviridae, heart failure, heart, arrhythmogenic right ventricular dysplasia, viruses, satellite viruses, therapeutics, plakophilins, mutation, cardiomyopathies | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map